Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9357 |
Short Description | Valrubicin injection |
Long Description | Injection, valrubicin, intravesical, 200 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2009-01-01 |
Date Added | 2000-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
24201010104 | J9357 | Valrubicin injection | VALRUBICIN | LEUCADIA PHARMACEUTICALS | 200 MG | 5 | 4 | 1 | 4 |
67979000101 | J9357 | Valrubicin injection | Valstar | ENDO PHARMACEUTICALS VALERA INC. | 200 MG | 5 | 4 | 1 | 4 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 200 MG |
HCPCS/CPT Billing Units | 0.005 |
Total doses ordered | |
Billing Units | 0.005 |
Drug Details
-
Valrubicin solution is used to treat a type of bladder cancer (carcinoma in situ; CIS) that was not effectively treated with another medication (Bacillus Calmette-Guerin; BCG therapy) in patients that can not have surgery right away to remove all or part of the bladder. However, only about 1 out of 5 patients responds to treatment with valrubicin and delaying bladder surgery may lead to the spread of bladder cancer which may be life-threatening. Valrubicin is an anthracycline antibiotic that is only used in cancer chemotherapy. It slows or stops the growth of cancer cells in your body.